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httpcense.Abstract Background: Supraventricular and ventricular arrhythmias, as well as conduction dis-
turbances are frequently observed in COPD and two major hypotheses for arrhythmogenesis have
been proposed: arrhythmias may be a consequence of hypoxaemia, hypercapnia or acid–base dis-
turbances since they increase the electrical heterogeneity within the ventricular wall or arrhythmias
may be the result of the autonomic neuropathy that characterizes COPD.
Aim of the work: In this study, we attempted to non-invasively verify these hypotheses in
hypoxaemic COPD patients that are not in respiratory failure by examining how PaO2, PaCO2,
pH and HCO3 correlate with QTd in those patients.
Subjects and methods: 25 COPD patients were subjected for Standard 12-lead ECG for arrhyth-
mia detection and the measurement of QT intervals, chest X-ray, two dimensional echocardiogra-
phy and myocardial nuclear imaging to exclude IHD.
Results: We found negative signiﬁcant correlation between O2 tension and the occurrence of
fatal arrhythmias; the same as between O2 tension and QTd value (P values were <0.0005 in both),
with QTd as the dependent variable, and age, pulmonary pressure, duration, Mg, Na, K, Hb PH,
CO2 and O2 tensions as the independent variables in all subjects, it was shown that only PaO2 was
the predictor of QTd with a P value of 0.02. In stable COPD patients enrolled in our study, new
cutoff levels for predicting arrhythmic fatality were proposed for the QTc parameter (395 ms with
a sensitivity of 92% and a speciﬁcity of 83%) and the QTd parameter (58 ms with a sensitivity of
100% and a speciﬁcity of 92%). There is a high positive signiﬁcant correlation between the age of
patients, duration of COPD and Hb level and the occurrence of fatal arrhythmias where P valuesotmail.com (H. Zaghla),
mir), moh-awad@yahoo.com
roush (H. Al Atroush).
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378 H. Zaghla et al.were 0.009, <0.0005 and <0.0005 respectively; the same as with QTd value where the P values were
0.015, 0.001 and 0.039. There is a positive signiﬁcant correlation between pulmonary pressure and
QTc where the P value was 0.041 and pulmonary pressure with QTd where the P value was 0.028.
Conclusion: Our results rule out the electropathy hypothesis and underline autonomic neuropa-
thy as the most possible mechanism of arrhythmias in hypoxaemic, non-respiratory failure, and
COPD patients.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Chronic obstructive pulmonary disease (COPD) represents an
increasing burden worldwide, reported to be the sixth leading
cause of death in 1990 and the fourth in 2000. Discouragingly,
it is projected to jump to the third place by the year 2020 [1].
Cardiovascular events are the predominant reason for hospi-
talizations (approximately 50% of all hospitalizations), the
second leading cause of mortality in subjects with mild to mod-
erate COPD, and they account for 20–25% of all deaths in
COPD [2]. Epidemiological studies have shown that reduced
lung function in subjects with COPD is associated with cardio-
vascular morbidity and mortality, even after taking into ac-
count smoking history [3]. The Lung Health Study reported
that a 10% decrement in lung function (forced expiratory vol-
ume in 1 s, FEV 1) among COPD patients is associated with a
30% increase in the risk of deaths from cardiovascular dis-
eases that included arrhythmias, heart failure, stroke, and car-
diopulmonary disease such as thromboembolic disease
(including an increased risk for pulmonary emboli and deep
vein thrombosis) and sudden death [4].
Aim of the work
The present work aimed to investigate:
a. The frequency of cardiac arrhythmias in patients with
stable COPD.
b. Their relation to QTc, QTd as predictors of cardiac
arrhythmia and the severity of hypoxaemia/
hypercapnia.
Subjects and methods
All patients were subjected to:
 Complete history taking including smoking index
 clinical examination
 Routine laboratory Arterial blood gases.
 Electrocardiographic Studies
 I Standard 12-lead ECG: for
 Arrhythmia detection.
 Measurement of QT Intervals:
QT parameters were measured from the 12-lead ECG
recording.
ECGs were recorded by means of a 12-channel ECG recor-
der (model 1709-A; Hewlett–Packard) at a paper speed of
50 mm/s (gain, 10 mm/millivolt). Before the measurement ofQT parameters, ECGs were enlarged on the same photocopier
by a factor of three.
The QT interval was measured from the onset of QRS com-
plex to the end of the T wave. In the presence of the U wave,
the end of the T wave was taken as the lowest point between
the T wave and the U wave. If the end of the T wave was
unclear, then it was excluded from analysis.
 A minimum of nine leads were studied in each patient. Min-
imum duration of the QT interval (QTmin), maximum
duration of the QT interval (QTmax), and their difference
(QTd) were measured. Each QT interval was corrected for
patient heart rate according to Bazett (1920) [5]:
QTc = QT/
p
RR interval, where QT and R-R interval
are expressed in seconds.
 Holter recordings:
Echocardiographic examination:
Nuclear imaging: to exclude patients with ischaemic heart
disease.
Statistical analysis and data management
Data were statistically described in terms of mean ± standard
deviation (± SD), median and range, or frequencies (number
of cases) and percentages when appropriate. Comparison of
numerical variables between the study groups was done using
the Mann Whitney U test for independent samples. P Values
less than 0.05 were considered statistically signiﬁcant. All sta-
tistical calculations were done using computer programs SPSS
(Statistical Package for the Social Science; SPSS Inc., Chicago,
IL, USA) version 15 for Microsoft Windows.Results
The present study group includes 25 pts with a mean age of
58.6±6.9 years (ranging from 47 to 72), 19 male (76%) and
6 females (24%) presented with stable chronic obstructive pul-
monary disease with a mean disease duration of 5.4 ± 3 years
(ranging from 1 to 12 years).
The following parameters were analysed:Laboratory investigations
The study group was non-anaemic with the Hb level ranging
from 12.5 to 16.5 gm/dL (N= 13–17 gm/dL in males and
11–16 gm/dL in females) and with normal electrolytes level
(Na, K, and Mg) as to exclude anaemia and electrolyte distur-
bances from being shared in arrhythmogenesis.
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Figure 1 Percentage of each arrythmia in the study group.
Figure 2 Percentage of fatal to non-fatal arrhythmias.
Arrhythmias in patients with chronic obstructive pulmonary disease 379As regards the ABG parameters, the study group patients
were selected with normal to compensated PH levels ranging
from 7.36 to 7.48 (N= 7.35–7.45), normal to compensated
HCO3 levels ranging from 18 to 30 mEq/L (N= 22–26 mEq/
L), normal to mild derangements in PaCO2 levels from 30 to
50 mmHg with secondary renal HCO3 and PH compensation
and PaO2 levels P60 and <85 mmHg except in one patient
which was 95 mmHg (N= 85–100 mmHg) so as to investigate
chronic hypoxaemic patients and not hypoxic ones.
Echocardiographic data
The study group shows normal left atrial diameter values rang-
ing from 3 to 4.3 cm (N= 2–4 cm), normal left ventricular
end-diastolic diameter values ranging from 4.3 to 5.5 cm
(N= 3.5–5.7 cm), normal left ventricular end-systolic diame-
ter values ranging from 2.7 to 3.9 cm (N= 2–4 cm), normal
ejection fraction values ranging from 58 to 65% (N= 53–
75%) to exclude heart failure and dilated cadiomyopathic pa-
tients and mild to moderately elevated pulmonary artery pres-
sure values ranging from 26 to 55 mmHg (N= 25/10 mmHg)
with no right ventricularization of the interventricular septum.
Electrocardiographic data
As shown in Table 1, the study group shows Qt dispersion val-
ues ranging from 38 to 80 ms (N= 40–50 ms) with a mean of
60.8 ± 11.4 where the risk for serious ventricular arrhythmias
or sudden death was observed in subjects with QT dispersion
greater than 65 ms values and corrected Qt interval values
ranging from 350 to 480 ms (N is up to 440 ms) with a mean
of 401.2 ± 34.
Frequency of arrhythmias
Four pts out of our 25 pts had inappropriate sinus tachycardia
(16%), 4 pts presented with arrhythmias in the form of PACs
(16%), 3 pts with monomorphic PVCs (12%), 3 pts with poly-
morphic PVCs (12%), 7 pts with non-sustained VT (28%), one
patient with AF(4%) and 3 cases with PVCs in salvoes (12%)
(Fig. 1).
Of these arrhythmias 3 types were considered fatal; poly-
morphic PVCs, PVCs in salvoes and non-sustained VT
(13 pts = 52%) while the rest represented the non-fatal ones
(12 pts = 48%) (Fig. 2).
Comparison of different parameters between fatal and non-fatal
arrhythmias
As shown in Table 2, the mean ± SD of age was 60 ± 7 years
in fatal arrhythmias vs. 53 ± 4.9 years in non-fatal arrhyth-
mias, a high signiﬁcant difference was observed between the
two groups. Also, a high signiﬁcant difference was seen on
comparing the mean ± SD of duration of COPD (7.5 ± 2.3Table 1 shows mean and SD of QTd and QT.
Mean ± SD Range
Qtd 60.8 ± 11.4 38–80
Qtc 401.2 ± 34 350–480in fatal vs. 2.8 ± 1.3 years in non-fatal), Hb level
(15.4 ± 0.95 in fatal vs. 13.8 ± 0.78 gm/dl in non-fatal), O2
tension (68.7 ± 4.7 in fatal vs. 80.2 ± 5.3 mmHg in non-fatal),
left atrium diameter (4.00 ± 0.21 in fatal vs. 3.6 ± 0.41 cm in
non-fatal) and pulmonary pressure (43.5 ± 8.3 in fatal vs.
33.5 ± 8.3 mmHg in non-fatal).
While no signiﬁcant difference was observed between the
two groups on comparing the mean ± SD of PaCO2
(39.0 ± 5.5 in fatal vs. 38.2 ± 4.0 mmHg in non-fatal),
HCO3 (25.8 ± 2.8 in fatal vs. 24.5 ± 2.15 mEq/L in non-fatal)
and PH (7.4 ± 0.02 in fatal vs. 7.4 ± 0.03 in non-fatal).
Also, no signiﬁcant difference was observed between the
two groups on comparing the mean ± SD of LV internal
dimensions and EF.
The mean ± SD of QTc was found to be higher in fatal
arrhythmias (422.3 ± 29.2) than in non-fatal arrhythmias
(378.3 ± 22.5), the mean ± SD of QTd was 69.7 ± 5.9 in fatal
vs. 51.25 ± 7.2 in non-fatal with a high statistical difference.
Comparison of different parameters according to QTd
When subjects were divided according to QTd value = 65 ms
as a predictor of arrhythmic fatality, 12 cases were found to
have QTd >65 ms while 13 cases with QTd <65 ms. On com-
paring the mean of different parameters between the 2 groups,
the mean ± SD of age was 60 ± 7.1 in cases with QTd
>65 ms vs. 53 ± 5.2 years in QTd <65 ms, a high signiﬁcant
difference was observed between the two groups. Also, a high
signiﬁcant difference was seen on comparing the mean ± SD
of duration of COPD (7.1 ± 3.4 in QTd >65 ms vs.
2.7 ± 2.0 years in QTd <65 ms), Hb level (15.1 ± 1.1 in
QTd >65 ms vs. 14.2 ± 1.1 gm/dl in QTd <65 ms), O2
tension (68.8 ± 4.9 in QTd >65 ms vs. 79.2 ± 6.0 mmHg in
QTd <65 ms), left atrium diameter (3.99 ± 0.23 in QTd
Table 2 shows the mean and standard deviation of different parameters in fatal and non-fatal arrhythmias using the student’s t test.
Fatal arrhythmias
(n= 13)
Non-fatal arrhythmias
(n= 12)
P value
Age 60 ± 7 53 ± 4.9 0.009**
Duration 7.5 ± 2.3 2.8 ± 1.3 <0.0005**
Hb 15.4 ± 0.95 13.8 ± 0.78 <0.0005**
PaO2 68.7 ± 4.7 80.2 ± 5.3 <0.0005
**
PaCO2 39.0 ± 5.5 38.2 ± 4.0 0.677
HCO3 25.8 ± 2.8 24.5 ± 2.15 0.189
PH 7.4 ± 0.02 7.4 ± 0.03 0.371
LA 4.00 ± 0.21 3.6 ± 0.41 0.009**
LVED 4.8 ± 0.45 4.8 ± 0.35 0.981
LVES 3.2 ± 0.38 3.2 ± 0.24 0.814
EF 60.7 ± 2.6 62.4 ± 2.9 0.131
Pulmonary pressure 43.5 ± 8.3 33.5 ± 8.3 0.006**
QTc 422.3 ± 29.2 378.3 ± 22.5 <0.0005**
QTd 69.7 ± 5.9 51.25 ± 7.2 <0.0005**
** P< 0.01.
Table 3 shows the mean and standard deviation of different
parameters according to QTd value using the student’s t test.
QTd >65 ms
(n= 12)
QTd <65 ms
(n= 13)
P value
Age 60 ± 7.1 53.5 ± 5.2 0.015*
Duration 7.1 ± 2.7 3.4 ± 2.0 0.001**
Hb 15.1 ± 1.1 14.2 ± 1.1 0.039*
PaO2 68.8 ± 4.9 79.2 ± 6.0 <0.0005
*
PaCO2 38.6 ± 5.9 38.7 ± 3.7 0.983
HCO3 25.3 ± 3.4 25.2 ± 1.8 0.927
PH 7.43 ± 0.025 7.42 ± 0.03 0.765
LA 3.99 ± 0.23 3.6 ± 0.42 0.017*
LVED 4.8 ± 0.45 4.8 ± 0.35 0.679
LVES 3.2 ± 0.39 3.2 ± 0.24 0.992
EF 60.9 ± 2.6 62.1 ± 3.1 0.313
Pulmonary pressure 41.7 ± 9.5 35.8 ± 9.1 0.126
380 H. Zaghla et al.>65 ms vs. 3.6 ± 0.42 cm in QTd <65 ms) and pulmonary
pressure (41.7 ± 9.5 in QTd >65 ms vs. 35.8 ± 9.1 mmHg
in QTd <65 ms).
While no signiﬁcant difference was observed between the
two groups on comparing the mean ± SD of PaCO2
(38.6 ± 5.9 in QTd >65 ms vs. 38.7 ± 3.7 mmHg in QTd
<65 ms), HCO3 (25.3 ± 3.4 in QTd >65 ms vs.
25.2 ± 1.8 mEq/L in QTd <65 ms) and PH (7.43 ± 0.025 in
QTd >65 ms vs. 7.42 ± 0.03 in QTd <65 ms).
Also, no signiﬁcant difference was observed between the
two groups on comparing the mean ± SD of LV internal
dimensions and EF.
The mean ± SD of QTc was found to be higher in QTd
>65 ms (428.3 ± 24.4) than in QTd <65 ms (376 ± 18.9),
the mean ± SD of QTd was 69.7 ± 5.9 in QTd >65 ms vs.
51.25 ± 7.2 in QTd <65 ms with a high statistical difference.QTc 428.3 ± 24.4 376 ± 18.9 <0.0005**
QTd 71 ± 4.8 51.5 ± 6.3 <0.0005**
** P< 0.01.
Comparison of different parameters according to QTc
When subjects were divided according to QTc value = 440 ms
as a predictor of arrhythmic fatality, 5 cases were found to have
QTc >440 ms while 20 cases with QTc <440. On comparing
the mean of different parameters between the 2 groups, the
mean ± SD of age was 62 ± 9.9 in cases with QTc >440 ms
vs. 55.4 ± 5.5 years in QTc <440, no signiﬁcant difference
was observed between the two groups. A high signiﬁcant differ-
ence was seen on comparing the mean ± SD of duration of
COPD (8.6 ± 2.2 in QTc >440 ms vs. 4.4 ± 2.6 years in QTc
<440 ms), Hb level (15.7 ± 0.6 in QTc >440 ms vs.
14.4 ± 1.2 gm/dl in QTc <440 ms), O2 tension (64.6 ± 3.4 in
QTc >440 ms vs. 76.7 ± 6.3 mmHg in QTc <440) (Table 3).
No signiﬁcant difference was observed between the two
groups on comparing the mean ± SD of PaCO2 (38.8 ± 6.6
in QTc >440 ms vs. 38.6 ± 4.4 mmHg in QTc <440),
HCO3 (25.2 ± 2.8 in QTc >440 ms vs. 25.2 ± 2.6 mEq/L in
QTc <440 ms) and PH (7.42 ± 0.035 in QTc >440 ms vs.
7.42 ± 0.028 in QTc <440 ms).
Also, no signiﬁcant difference was observed between two
groups on comparing the echocardiographic data (LA, LVED
and LVES dimensions, EF and PH).The mean ± SD of QTc was found to be higher in QTc
>440 ms (452 ± 17.9) than in QTc <440 ms (388.5 ± 23.5),
the mean ± SD of QTd was 74.2 ± 3.6 in QTc >440 ms vs.
57.5 ± 10.1 in QTc <440 ms with a high statistical difference.
Predictive values for arrhythmic fatality
a. ROC curve reveals the following: the AUC for QTc was
0.904 at a cutoff level of 395 ms, the sensitivity was 92%
and the speciﬁcity was 83% (Fig. 3 Table 4).
b. ROC curve reveals the following: the AUC for QTd was
0.962 at a cutoff value of 58 ms, the sensitivity was 100%
and the speciﬁcity was 92% (Fig. 4).
Correlation between different parameters
A. The correlation between PaO2 and QT interval
parameters:
ROC Curve
Diagonal segments are produced by ties.
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Figure 3 An ROC curve for deﬁning a predictive value for
arrhythmic fatality in our patients using QTc parameter.
Table 4 shows the mean and standard deviation of different
parameters according to QTc value using the student’s t test.
QTc >440 ms
(n= 5)
QTc <440 ms
(n= 20)
P value
Age 62 ± 9.9 55.4 ± 5.5 0.053
Duration 8.6 ± 2.2 4.4 ± 2.6 0.003**
Hb 15.7 ± 0.6 14.4 ± 1.2 0.039*
PaO2 64.6 ± 3.4 76.7 ± 6.3 <0.0005
**
PaCO2 38.8 ± 6.6 38.6 ± 4.4 0.961
HCO3 25.2 ± 2.8 25.2 ± 2.6 1.000
PH 7.42 ± 0.035 7.42 ± 0.028 0.947
LA 4.00 ± 0.25 3.8 ± 0.39 0.129
LVED 5.2 ± 0.29 4.8 ± 0.39 0.051
LVES 3.4 ± 0.33 3.2 ± 0.31 0.262
EF 60.8 ± 3.0 61.7 ± 2.8 0.534
Pulmonary pressure 42.6 ± 10.7 37.7 ± 9.4 0.317
QTc 452 ± 17.9 388.5 ± 23.5 <0.0005**
QTd 74.2 ± 3.6 57.5 ± 10.1 <0.0005**
** P< 0.01.
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Figure 4 An ROC curve for deﬁning a predictive value for
arrhythmic fatality in our patients using the QTd parameter.
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Figure 5 Correlation of O2 saturation with QTc (P< 0.0005,
r= 0.823).
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Figure 6 Correlation of O2 saturation with QTd (P< 0.0005,
r= 0.898).
Arrhythmias in patients with chronic obstructive pulmonary disease 381As regards analysis of the correlations between hypoxaemia
and QT interval parameters, a high negative signiﬁcant corre-
lation was seen between PaO2 and QTc (P< 0.0005,
r= 0.823) and PaO2 with QTd (P< 0.0005, r= 0.898)
(Figs. 5 and 6).
A. The correlation between pulmonary pressure and QT
interval parameters:
As regards analysis of the correlations between pulmonary
pressure and QT interval parameters, a positive signiﬁcant cor-
relation was seen between pulmonary pr. and QTc (P= 0.041,
r= 0.412) and pulmonary pr. with QTd (P= 0.028, r
= 0.438) (Figs. 7 and 8).
A. The correlation between the duration of COPD and
QT interval parameters:
360.00
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Linear Regression with
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qtc = 344.51 + 1.47 * pulmp
R-Square = 0.17
Figure 7 Correlation of pulmonary pressure to QTc (P= 0.041,
r= 0.412).
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R-Square = 0.19
Figure 8 Correlation of pulmonary pressure to QTd (P= 0.028,
r= 0.438).
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Linear Regression with
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qtc = 356.30 + 8.57 * duration
R-Square = 0.58
Figure 9 Correlation of the duration of COPD to QTc
(P< 0.0005, r= 0.759).
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Linear Regression with
95.00% Mean Prediction Interval
qtd = 44.71 + 3.08 * duration
R-Square = 0.66
Figure 10 Correlation of duration of COPD to QTd
(P< 0.0005, r= 0.815).
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qtc = 243.41 + 2.59 * qtd
R-Square = 0.75
Figure 11 Correlation of QTD to QTc (P< 0.0005, r= 0.867).
Table 5 The relation between arrhythmic fatality and the
QTd cut off value.
Fatality Total
Non-fatal arrhythmias Fatal arrhythmias
QTd <65 ms 11 2 13
QTd >65 ms 1 11 12
Total 12 13 25
P< 0.0005.
382 H. Zaghla et al.As regards analysis of the correlations between the duration
of COPD and QT interval parameters, a positive signiﬁcant
correlation was seen between pulmonary pr. and QTc
(P< 0.0005, r= 0.759) and pulmonary pr. with QTd
(P< 0.0005, r= 0.815) (Figs. 9 and 10).
A. The correlation between QTd and QTc:
A high positive signiﬁcant corelation between QTd and
QTc (P< 0.0005, r= 0.867) (Fig. 11).
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Figure 12 The relation between arrhythmic fatality and the QTd
cut off value.
ROC Curve
Diagonal segments are produced by ties.
1 - Specificity
1.00.75.50.250.00
Se
ns
iti
vi
ty
1.00
.75
.50
.25
0.00
Figure 13 An ROC curve for deﬁning duration.
Arrhythmias in patients with chronic obstructive pulmonary disease 383The relation between fatality and QTd
As shown in Table 5: Out of the 12 cases of non-fatal arrhyth-
mias, 11 cases had a QTd <65 ms and one case had a QTd
>65 ms, while of 13 cases of fatal arrhythmias, 2 cases had
a QTd <65 ms and 11 cases were with QTd >65 ms Fig. 12.
A high signiﬁcant agreement between fatality and QTd was
observed (P< 0.0005) (Fig. 13).
Impact of different parameters on QTd
On analysing the impact of different parameters on QTd,
regression analysis showed that only PaO2 was the predictor
of QTd (P< 0.05), Overall multiple regression analysis be-
tween QTd (dependent variable) and age, pulmonary pressure,
duration, Mg, Na, K, PH, Hb, and CO2 (independent vari-
ables) in all subjects.
Multiple stepwise regression analysis was performed with
QTd as the dependent variable, and by entering the indepen-
dent variable with the highest partial correlation coefﬁcient
at each step, with a F-value probability for the inclusion of
0.05 and 0.01 for removal.We performed multiple regression analysis including all the
parameters in the statistical model that resulted to be signiﬁ-
cantly correlated to QTd (age, pulmonary pressure, duration,
Mg, Na, K, PH, Hb, and CO2). The ANOVA inﬂation factors
excluded multicollinearity for these variables.
ROC curve reveals the following: the AUC for QTc was
0.971 at a cutoff level of 4.5, the sensitivity was 92% and the
speciﬁcity was 8.Discussion
The cardiac manifestations of chronic obstructive pulmonary
disease (COPD) are numerous. Impairments of right ventricu-
lar dysfunction and pulmonary vascular disease are well
known to complicate the clinical course of COPD and corre-
late inversely with survival. The coexistence of COPD and
coronary artery disease occurs frequently. This association is
likely related to shared risk factors as well as similar patho-
genic mechanisms, such as systemic inﬂammation [6].
Arrhythmias occur frequently in patients with COPD.
Fatal arrhythmias are a common cause of death in chronic
obstructive pulmonary disease (COPD). Two major hypothe-
ses for arrhythmogenesis in COPD have been proposed: The
ﬁrst hypothesis (electropathy) implicates hypoxaemia, hyper-
capnia and acid–base disturbances as the three main, COPD-
related, arrhythmogenic triggers. The second hypothesis pro-
poses autonomic neuropathy as the arrhythmogenic trigger [7].
Autonomic neuropathy has been associated with a pro-
longed electrocardiograph QTc interval and risk of ventricular
arrhythmias and death [8].
QT dispersion reﬂects in homogenecity of ventricular repo-
larization. It is calculated using 12-leads standard synchro-
nized ECG or 24-h Holter monitoring. Increased QT
dispersion has prognostic value for sustained ventricular
tachycardia. Dispersion of repolarization > or = 65 ms is a
risk factor for sudden cardiac death [9].
The present study included twenty- ﬁve stable COPD pa-
tients with a mean age of 58.6 ± 6.9 years (ranging from 47
to 72), 19 male (76%) and 6 females (24%), recruited from
the Outpatient Clinic- Chest Department of the Kasr El einy
Hospital. They were diagnosed according to criteria of the
American Thoracic Society.
A thorough assessment including history taking, physical
examination with measurement of lab (haemoglobin, Na, K,
Mg, PaO2, PaCO2, HCO3 and PH), echocardiographic (LV
internal dimensions, global systolic function and pulmonary
artery pressure) and electrocardiographic (Qtc and Qtd)
parameters were done for each subject.
The present report attempts to examine the frequency of
various cardiac arrhythmias in COPD patients as well as
focusing on the logical physiological consequences of the two
competing theories in order to establish which of the two
hypotheses is correct. Indeed, the logical consequence of both
theories is that, depending on the effectiveness of the acid–base
compensatory mechanisms, all of PaO2, PaCO2, pH and HCO3
will be affected in COPD.
On the other hand, if the hypothesis of electropathy is cor-
rect, one should expect that factors related to PaCO2, that is
pH and HCO3, will strongly correlate with QT dispersion
(QTd), which is a non-invasive index of ventricular repolarisa-
tion heterogeneity. Conversely, if autonomic neuropathy is the
384 H. Zaghla et al.basis of COPD arrhythmogenesis, one would expect that only
those parameters that directly and strongly inﬂuence neuronal
excitability, that is PaO2, will strongly correlate with QTd. In
order to discern which of the two hypotheses is correct, we
examined how the classical indices of electropathy, such as
PaO2, PaCO2, pH and HCO3, correlate with QTd in patients
with stable COPD.
We used QTd as an index of the electrophysiological re-
sponse of myocardial cells to hypoxaemia, hypercapnia and
acid–base disturbances.
The present study revealed that:
Four pts out of our 25 pts had inappropriate sinus tachy-
cardia (16%), 4 pts presented with arrhythmias in the form
of PACs (16%), 3 pts with monomorphic PVCs (12%), 3 pts
with polymorphic PVCs (12%), 7 pts with non-sustained VT
(28%), one patient with AF(4%) and 3 cases with PVCs in
salvoes (12%). Of these arrhythmias 3 types were considered
fatal; polymorphic PVCs, PVCs in salvoes and non-sustained
VT. (13 pts = 52%) while the rest represented the non-fatal
ones (12 pts = 48%).
These results are in agreement with the study of 13 COPD
patients reported by Ciobanu et al., who concluded that ven-
tricular premature beats were the most frequent arrhythmias
in those patients and stated that there are no current studies
showing the precise prevalence of cardiac arrhythmias in
COPD patients [10].
There is no signiﬁcant correlation between PaCO2, HCO3
and PH and the occurrence of fatal arrhythmias; the same as
with QTd and QTc values.
These results are in agreement with the study of 29 stable
COPD patients reported by Theoﬁlogiannakos et al., who
hypothesised that, if the electropathy theory was correct, a high
correlation between QTd and pH or HCO3 would be found.
However, they did not ﬁnd any statistically signiﬁcant correla-
tion that would indicate that the hypothesis of electropathy
may be correct [7].
There is a high negative signiﬁcant correlation between
O2 tension and the occurrence of fatal arrhythmias where
the P value was <0.0005; the same as between O2 ten-
sion and the QTd value; as a predictor of arrhythmic
fatality and the QTc value where the P was <0.0005 va-
lue in both.
*In multiple regression analyses, with QTd as the dependent
variable, and age, pulmonary pressure, duration, Mg, Na, K,
Hb PH, CO2 and O2 tensions as the independent variables in
all subjects, it was shown that only PaO2 was the predictor
of QTd with a P value of 0.02.
Autonomic neuropathy is the second arrhythmogenic
mechanism that has been proposed in COPD. Chronic hypox-
aemia is a signiﬁcant factor in the pathophysiology of auto-
nomic neuropathy and it has been considered to be the
underlying cause of COPD autonomic neuropathy.
Scalvini et al. submitted a study aiming to detect if
chronically hypoxaemic COPD patients may suffer from
abnormal behaviour of the ANS as assessed by a signiﬁcant
reduction in HRV and a markedly abnormal response to
vagal and sympathetic stimuli such as controlled breathing
and tilting, respectively. This study also showed that correc-
tion of hypoxaemia partially reverses these abnormalities
[11].
This comes in agreement with evidence suggested by Chh-
abra and De on their study on 56 patients with mild formsof COPD that autonomic neuropathy can appear even in the
very early stages of the disease [12].
This also comes in agreement with the study of 13 COPD pa-
tients reported by Ciobanu et al., who concluded that ventricu-
lar premature beats were the most frequent arrhythmias in
those patients, being recorded at two peaks, one corresponding
to the lunchtime (between 1 and 2 pm) due to hypoxaemia oc-
curred while eating, and another one in the early morning (be-
tween 2 and 4 am) due to nocturnal hypoxaemia [10].
There is a high positive signiﬁcant correlation between the
age of patients, duration of COPD and Hb level and the occur-
rence of fatal arrhythmias where the P values were 0.009,
<0.0005 and <0.0005 respectively; the same as with the
QTd value where P values were 0.015, 0.001 and 0.039.
There is a positive signiﬁcant correlation between pulmon-
ary pr. and QTc where the P value was 0.041 and pulmonary
pr. with QTd where the P value was 0.028.
This comes in agreement with the study of 201 patients with
pulmonary hypertension reported by Hong-liang et al. who
concluded that mean QTc and QTcd are positively correlated
to mean pulmonary arterial pressure and are signiﬁcantly in-
creased in patients with severe pulmonary hypertension [13].
There is a high signiﬁcant agreement between arrhythmic
fatality and QTd value where the P value was <0.0005.
This comes in agreement with the study of 30 patients with
COPD reported by Yildiz et al. who found that daily VPB
rates were signiﬁcantly higher in patients with prolonged
QTd (>60 ms) as compared to patients with shorter QTd
intervals (<60 ms) and that patients with runs of VT had long-
er QTd compared to patients without VT [8]. These ﬁndings; as
he stated, suggested that increased QTd was associated with in-
creased risk of malignant cardiac arrhythmia and may be clin-
ically important in patients with COPD. Although patients
with COPD with QTd <60 ms had longer QTd compared to
control subjects, VPB frequency and runs of VT were not sta-
tistically different. This ﬁnding implies that the predictive va-
lue of QTd may become apparent only after reaching a
certain threshold level.
In stable COPD patients enrolled in our study, new cutoff
levels for predicting arrhythmic fatality were proposed for
the QTc parameter (395 ms with a sensitivity of 92% and a
speciﬁcity of 83%) and the QTd parameter (58 ms with a sen-
sitivity of 100% and a speciﬁcity of 92%).Summary and conclusion
COPD is characterised by irreversible airﬂow limitations and
symptoms, such as chronic cough, wheezing, expectoration
and dyspnoea. Although COPD is an important cause of mor-
bidity and mortality, a large proportion of its mortality is not
of pulmonary origin.
Traditionally, it was considered that patients with COPD
are at special risk of cardiovascular diseases. COPD increases
the risk of cardiovascular disease two- to threefold, and it has
been proposed that low-grade systemic inﬂammation in pa-
tients with COPD is strongly associated with their increased
risk of cardiovascular injury.
Apart from ischaemic heart disease, supraventricular and
ventricular arrhythmias, as well as conduction disturbances
are frequently observed in COPD. Many factors have been
implicated as potential triggers of COPD-related arrhythmias.
Arrhythmias in patients with chronic obstructive pulmonary disease 385In the present study, we attempted to non-invasively
verify these hypotheses in hypoxaemic COPD patients
who are not in respiratory failure by examining how
PaO2, PaCO2, pH and HCO3 correlate with QTd in those
patients.
All our 25 patients with chronic obstructive pulmonary dis-
ease underwent:
1-Full history, clinical examination and laboratory
investigation.
We found negative signiﬁcant correlation between O2 ten-
sion and the occurrence of fatal arrhythmias where the P value
was <0.0005; the same as between O2 tension and the QTd va-
lue; as a predictor of arrhythmic fatality and QTc value where
the P value was <0.0005 in both.
 In multiple regression analyses, with QTd as the dependent
variable, and age, pulmonary pressure, duration, Mg, Na,
K, Hb PH, CO2 and O2 tensions as the independent vari-
ables in all subjects, it was shown that only PaO2 was the
predictor of QTd with a P value of 0.02.
 In stable COPD patients enrolled in our study, new
cutoff levels for predicting arrhythmic fatality were
proposed for the QTc parameter (395 ms with a sensitivity
of 92% and a speciﬁcity of 83%) and the QTd param-
eter (58 ms with a sensitivity of 100% and a speciﬁcity
of 92%).
 Also in this study we found that there is a high positive sig-
niﬁcant correlation between the age of patients, duration of
COPD and Hb level and the occurrence of fatal arrhyth-
mias where P values were 0.009, <0.0005 and <0.0005
respectively; the same as with the QTd value where P values
were 0.015, 0.001 and 0.039.
 There is a positive signiﬁcant correlation between pulmon-
ary pr. and QTc where the P value was 0.041 and pulmon-
ary pr. with QTd where the P value was 0.028.
In conclusion, our results rule out the electropathy hypoth-
esis and underline autonomic neuropathy as the most possible
mechanism of arrhythmias in hypoxaemic, non-respiratory
failure, and COPD patients.
Recommendations
 Based on the results of this study, future research is recom-
mended in a larger cohort to conﬁrm that autonomic neu-
ropathy is the most possible arrhythmogenic mechanism
in stable COPD patients.
 The addition of Heart Rate Variability study(HRV) to QTd
as an index of autonomic nervous system function and as a
predictor of future arrhythmic events. The new cutoff levels for predicting arrhythmic fatality that
were proposed in our study for QTc and QTd parameters
deserve further multicenter studies with larger sample sizes
to verify their accuracy and applicability.
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